您现在的位置是:幻浪视界 > 探索
Weight regain happens 4x faster after stopping GLP
幻浪视界2026-02-01 05:25:14【探索】9人已围观
简介Facebook TwitterThreads FlipboardCommentsPrintEmailAdd Fox News on GoogleWeigh
- Threads
- Comments
- Add Fox News on Google
Weight-loss journeys can cause social strains for GLP-1 patients, doctor says
Dr. Rocio Salas-Whalen shares how rapid GLP-1–driven weight reductions leave many individuals confronting psychological challenges that complicate relationships and social routines.
NEWYou can now listen to Fox News articles!Discontinuing the use of GLP-1 weight-loss medications triggers weight regain more than previously thought, a new study suggested.
The research, which was published in The BMJ, found that stopping the drugs is also associated with a reversal of improvements in heart and metabolic health, including cholesterol and blood pressure.
University of Oxford researchers analyzed 37 studies published up to February 2025, involving more than 9,000 participants who had undergone an average of 39 weeks of weight-loss treatment.
OLDER AMERICANS ARE QUITTING GLP-1 WEIGHT LOSS DRUGS FOR 4 KEY REASONS
On average, patients regained about 0.9 pounds per month after stopping treatment. Researchers estimated that body weight and risk markers for diabetes and heart disease would return to pre-treatment levels in less than two years.

On average, patients regained about 0.9 pounds per month after stopping treatment. (iStock)
The analysis also revealed that the weight came back on nearly four times faster than after changing or quitting a diet or exercise regimen, no matter how many pounds had been shed.
OBESITY EXPERT REVEALS THE BEST WAY TO DECIDE IF GLP-1S ARE RIGHT FOR YOU
"The evidence suggests that despite their success in achieving initial weight loss, these drugs alone may not be sufficient for long-term weight control," the researchers commented in a press release.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The study authors acknowledged that only eight studies assessed treatment with newer GLP-1 drugs, at a maximum follow-up period of 12 months after the medication was stopped. This could serve as a limitation, although three additional methods of analysis provided similar results.

These findings question the effectiveness of GLP-1s for long-term weight loss, the researchers noted. (iStock)
In an editorial responding to the study, Dr. Qi Sun, associate professor of medicine at Brigham and Women’s Hospital and Harvard Medical School, wrote that these findings "cast doubt" on the idea that GLP-1s are a "perfect cure for obesity."
CLICK HERE FOR MORE HEALTH STORIES
"People taking GLP-1 receptor agonists should be aware of the high discontinuation rate and the consequences of cessation of medications," he said. "Healthy dietary and lifestyle practices should remain the foundation for obesity treatment and management, with medications such as GLP-1 receptor agonists used as adjuncts."
"Many of the patients who quit their GLP-1 drugs could have stayed on them with the right personalized care."
很赞哦!(34143)
站长推荐
友情链接
- 墙贴怎么使用 墙贴装修有哪些特点
- 墨守孤城最新礼包兑换码分享
- 2021中国新疆伊犁天马国际旅游节即将启幕
- 让垃圾分类成为生活新时尚
- 毕业论文结尾感谢致辞
- 《Diceball》PC版下载 Steam正版分流下载
- [新浪彩票]足彩第25186期大势:14场派奖1200万
- 2026中国冬季项目十支国家队比赛装备发布 安踏创新科技助力中国健儿出征米兰
- [新浪彩票]足彩25186期盈亏指数:法兰克福防平
- [新浪彩票]足彩25186期投注策略:切尔西防平
- “北溪”爆炸案一嫌犯身份曝光:案发时为乌军现役士兵
- CBA与咪咕,真的走不到一起了吗?
- 前14场赛事现场观众累计390万创新高,F1 2025赛季前半程亮点回顾
- 肩部酸痛的形成原因及饮食原则
- 综漫:我和万界天之骄女五感互通
- [新浪彩票]足彩第25190期大势:曼城皇马可作胆
- F1与美国大奖赛续约
- Mỹ tấn công đáp trả, oanh tạc 70 mục tiêu trên khắp Syria
- 六安市:“空间焕活”背后的民生考题
- F1与摩纳哥大奖赛续约至2035年






